S&P 500 (NYSE:SPY) component Bristol-Myers Squibb Co. (NYSE:BMY) will unveil its latest earnings on Thursday, April 26, 2012. Bristol-Myers Squibb is a global company that develops, manufactures, and sells pharmaceutical products.
Bristol-Myers Squibb Co. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for profit of 61 cents per share, a rise of 5.2% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved up from 60 cents. Between one and three months ago, the average estimate moved up. It has dropped from 63 cents during the last month. Analysts are projecting profit to rise by 14% compared to last year’s $1.96.
Past Earnings Performance: The company missed estimates last quarter after beating forecasts in the prior two. In the fourth quarter of the last fiscal year, the company reported net income of 53 cents per share versus a mean estimate of profit of 55 cents per share. In the third quarter of the last fiscal year, the company beat estimates by 3 cents.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 4.8% in revenue from the year-earlier quarter to $5.25 billion.
Analyst Ratings: 11 out of 21 analysts surveyed (52.4%) have a buy rating on Bristol-Myers Squibb. This is below the mean analyst rating of 10 competitors, which average 55% buy ratings.
A Look Back: In the fourth quarter of the last fiscal year, profit rose 76.4% to $852 million (50 cents a share) from $483 million (28 cents a share) the year earlier, but fell short analyst expectations. Revenue rose 6.7% to $5.45 billion from $5.11 billion.
On the top line, the company can extend a streak of revenue increases in the last four quarters. Revenue rose 4.2% in the first quarter of the last fiscal year, 14% in the second quarter and 11.4% in the third quarter before climbing again in the fourth quarter.
Stock Price Performance: Between February 23, 2012 and April 20, 2012, the stock price had risen $2.20 (6.9%), from $32.03 to $34.23. The stock price saw one of its best stretches over the last year between September 9, 2011 and September 20, 2011, when shares rose for eight straight days, increasing 8% (+$2.26) over that span. It saw one of its worst periods between April 3, 2012 and April 10, 2012 when shares fell for five straight days, dropping 4.1% (-$1.40) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: